Heartflow CEO John Farquhar sells $1.47 million in company stock

Heartflow CEO John Farquhar, along with being a director at Heartflow, Inc. (NASDAQ: HTFL), sold 32,676 shares of common stock worth approximately $1.47 million on August 18, 2026, according to a recent regulatory filing. This sale was conducted under a Rule 10b5-1 trading plan that Mr. Farquhar established on September 12, 2025.

The shares were sold at $45 each, coinciding with Heartflow's stock price surging over 86% in the last six months, currently trading at $46.80, close to its 52-week high of $47.95. Post the transaction, Mr. Farquhar still directly holds 388,044 shares of Heartflow common stock. Based on InvestingPro analysis, the stock appears overvalued at its current price.

Investors can utilize 14 additional InvestingPro Tips and in-depth financial metrics to make more informed investment choices regarding HTFL. In related news, HeartFlow Inc. reported a smaller-than-expected loss for the second quarter of 2026, with adjusted earnings of negative $0.07 per share, beating Wall Street’s estimate of a negative $0.19 per share.

Revenue for the same period increased by 48% to $64.1 million, outpacing analysts' projections of $56.7 million and the consensus estimate of $56.6 million. HeartFlow's stock performance was boosted by heightened demand for its coronary artery disease diagnostic services, leading to a price target upgrade from Stifel to $45.00 from $40.00, with the firm maintaining a Buy rating.

These findings signify HeartFlow's continued growth and the favorable reception from analysts towards its financial performance.